levelogic.com_0001 - 2002-11-22 investment - lyris.stockuptics.com - delta-levelogic.com
Stupid spam
Home |
Articles |
Spams |
419 scams |
Spambots |
Deny list |
Phone list |
eMail list |
FAQ |
Forum
Remove requests |
Decode 64 |
Decode qp |
Decode ip |
Other sites |
Spam SUCKS! |
Formmail Scans
Logos |
Phishing |
Lottery Scams |
Support TOASTEDspam.com |
Network Testing Services |
PushPinMap
(3377) View this spam as a pruned html file
TOASTEDspam.com toasted spam dot com
|
levelogic.com_0001 - 2002-11-22 investment - lyris.stockuptics.com - delta-levelogic.com
|
Return-Path: <bounce-stockupticks-8666217@delta.levelogic.com>
Received: from delta.levelogic.com (delta.levelogic.com [64.157.40.131])
by www.munged.ext (8.11.6/8.11.6) with SMTP id gAMNXkj08776
Fri, 22 Nov 2002 18:33:47 -0500
X-Sent: 22 Nov 2002 21:17:39 GMT
Message-ID: <LISTMANAGERSQL-8666217-3926-2002.11.22-13.22.33--#munged.ext@lyris.stockupticks.com>
Date: Fri, 22 Nov 2002 13:27:36 -0800
From: "StockUpTicks" <bounce-stockupticks-8666217V@delta.levelogic.com>
X-Mailer: Mozilla 4.72 [en]C-CCK-MCD NSCPCD47 (Win98; U)
X-Accept-Language: en
Subject: AVHC Hits Home With Our Editor
List-Unsubscribe: <mailto:leave-stockupticks-8666217V@lyris.stockupticks.com>
Reply-To: "StockUpTicks" <customer_service@stockupticks.com>
[Stockupticks.com] [Image]
Welcome to the Stockupticks.com Newsletter! Issue # 95 - November 22,
2002
[Image]
[Image] [Image] [Image]
[Image] ADVANCED HEALTHCARE TECHNOLOGIES, INC., [Image]
(OTCBB: AVHC)
Dear Reader,
We’ve been publishing StockUpTicks for several years
and I’ve written a lot of our editorials and profiles.
There’s something interesting in most every story we do
and I enjoy drawing your attention to these
often-undiscovered stories.
But not like today.
Today I write you from the first person; from my own
personal story and experience.
A short while ago I was with my cousin who is among my
dearest friends. I grew up just three doors down from
him and his brothers, the eldest of which is Ken, who
had been hospitalized battling severe diabetes and a
wound that wouldn’t heal. I was with Ken’s brother when
he took a call from their father, my uncle, who was at
the hospital
Through the mobile phone I could hear my uncle in
tears, telling my cousin that they wanted to take Ken’s
leg; that amputation looked to be the only cure for a
diabetic wound that wouldn’t heal. “Don’t let them take
his foot, son,” my elderly uncle told my cousin,
imploring him to plead with the doctors to try
something else.
When I spoke to Phillip Loori, President of Advanced
Healthcare Technologies, Inc. (OTCBB: AVHC) the first
time, he told me about his company’s use of Hyperbaric
Oxygen Therapy to treat diabetic wounds that wouldn’t
heal. I told him about Ken’s plight and he kindly
offered to do whatever he could to help.
I hung up the phone, called my cousin and said that
this CEO had told me about a therapy that could save
Ken’s limb. I told him about Hyperbaric Oxygen Therapy
and what it was designed to do, how it might be perfect
for Ken.
He interrupted me and said, “He’s fine now. That’s what
saved his foot. They didn’t have to amputate.”
It’s one thing to hear about FDA approvals and clinical
trials. It’s another to know that the technology that
our featured company today is based upon is the reason
your loved one still can walk.
I hope you enjoy today’s profile.
[Image] - ABOUT AVHC - [Image]
Advanced Healthcare Technologies is a company
that engages in the acquisition of leading
technologies in the healthcare industry.
Principle acquisition targets consist of
companies in the Medical Devise and Medical
Service Industry.
Recent Acquisitions include: Advanced
[Image]Hyperbaric Technologies of Farmingdale, NJ.
Advanced Hyperbaric engages in the sale of
Topical Hyperbaric Oxygen chambers, which are
marketed to various healthcare organizations
including, wound care clinics and physical
therapy providers. AHT's principle products
include a portable topical Hyperbaric Oxygen
chamber and a The Disposable Sacral Topical
Hyperbaric Oxygen System for smaller wounds.
[Image] - THIS WEEK'S NEWS FROM AVHC - [Image]
Press Release
Source: Advanced Hyperbaric Technologies, Inc.
Wednesday November 20, 7:48 pm ET
Advanced Hyperbaric Technologies, Inc., a Subsidiary of
Advanced Healthcare Technologies, Inc., Announces the
Publishing of a New Topical Hyperbaric Oxygen Study
FARMINGDALE, N.J., Nov. 20 /PRNewswire/ -- Advanced
Hyperbaric Technologies, Inc., a subsidiary of Advanced
Healthcare Technologies, Inc. (OTC Bulletin Board: AVHC
- News) today announces the publishing of a new topical
hyperbaric oxygen study.
New Topical Hyperbaric Oxygen Study Published-
A study, published this week in a leading medical
journal, reports that treatments using AHT 's Topical
Hyperbaric Oxygen Products facilitate wound healing and
the full closure of pressure ulcers (bed sores) in
patients at long term care facilities (nursing homes).
The study was conducted by leading wound care
researchers and specialists. The study, conducted over
a four-week period, demonstrated a 34.4% decrease in
the average size of Stage III and Stage IV ulcers by
utilizing THBO Therapy. This is highly significant, as
many of these wound ulcers can remain open for years.
The study went on to show that by healing wounds with
THBO Therapy, suffering was reduced and quality of life
was improved.
To read the entire release and disclaimer, Click Here
-------------------
[Image]
Advanced Hyperbaric Technologies, Inc. is a
wholley-owned subsidiary of AHT that's engaged in the
sale of Topical Hyperbaric Oxygen Chambers for the
healing of open wounds. AHT's products are utilized to
treat patients who suffer from chronic open wounds due
to diabetes, vascular insufficiencies, post surgical
infections, amputations, frostbite and burns. The
chambers are marketed to hospitals, doctors, wound care
clinics, nursing homes, and patients.
[Image]
Topical Hyperbaric Oxygen raises tissue oxygen levels
at the wound site.
Oxygen: The body's fundamental mechanism for healing
itself. It is essential for any healing process -
especially chronic, recalcitrant open wounds. Oxygen is
vital in collagen synthesis, enhancement of
fibroblasts, angiogenesis and leucocyte function.
Topical Hyperbaric Oxygen: Raises tissue oxygen levels
at the wound site.
The Topical Hyperbaric Oxygen Extremity Chamber: Pulses
topical hyperbaric oxygen at intermittent pressure
directly to the wound site. The result is oxygen levels
are raised, wounds heal faster and the cost to heal the
wound is drastically reduced.
Currently, AVHC is conducting
[Image] research at two facilities that
specialize in wound healing and
wound healing research.
-------------------
One of the main goals of studies of this
type is to generate clinical information
necessary for Medicare and other insurance
providers to pay for Topical Hyperbaric
Oxygen Therapy in patient's homes as well
as on an outpatient basis.
The second research project is slated to
begin in December. AHT plans to commit
resources to the Northeast Center for
Special Care, a 250-bed spinal cord injury
[Image] center. In the study, researchers will
investigate the clinical efficacy of both
the disposable sacral chamber and the
extremity chamber.
The third research project is slated to
begin in January and will begin at a large
Wound Care Center in New York. The research
project will be a 100-patient controlled
study. A controlled study of this size is
significant as clinicians, when evaluating
treatments, look for controlled studies
with large numbers of patients treated.
[Image] - THE MARKETS FOR AVHC INNOVATION - [Image]
AVHC has already signed a distribution agreement with
Innovative Medical Systems, Inc. of St. Louis,
Missouri, a medical distributor, which is marketing the
chambers in the states of Illinois, Missouri and
Kansas.
As AVHC continues to increase its sales efforts in the
United States they are beginning to focus on an even
greater marketing opportunity, the international
market. AVHC is currently selling its products in
Canada, Spain and Israel.
AVHC is communicating with medical device distributors
in Japan, Jordan and Ireland who have contacted the
company seeking the opportunity to market the chambers
in their respective countries. Additionally, AHT is
working toward a strategic partner relationship with an
overseas company to be the master distributor of its
THBO products in Europe.
The European market is of great interest to AVHC as
diabetic foot ulcers continue to be the most common
cause of lower extremity amputations in Europe.
[Image] - COMPARATIVE TREATMENTS - [Image]
[Image]
What is the advantage of utilizing THBO instead of Full
Body HBO? The advantage of Topical delivery of
Hyperbaric Oxygen is the ability to achieve increased
oxygen tension in the wound without the risk of oxygen
toxicity. There is no systemic absorption when using
the topical HBO chamber. When using the Full Body
Chamber, you are breathing the oxygen, and by doing so,
you are directly exposing yourself or the patient to
the risk of central nervous system or pulmonary
toxicity, both of which have been reported in patients
who have been treated in Full Body Chambers.
Are there any side effects?
Full Body Topical HBO
Congestive Heart
Failure
Yes No
Severe
Claustrophobia
Yes No
Congestive Heart
Failure
Yes No
Nervous System Disorders
Yes No
Accelerates Cataract Growth
Yes No
Distorts Vision up to 8 week
Yes No
Pressure in the Ears and Sinus Cavity
Yes No
How much will it cost?
Full Body Chamber: $300.00 to $500.00 / day
Topical HBO Chamber: $75.00 / day
-------------------
Insurance
Most private insurance companies, including some
Medicare and Medicaid HMO Plans are approving Topical
Hyperbaric Oxygen Therapy on a case by case basis for
home car use. A prescription and a Letter of Medical
Necessity are required in order to start the
pre-approval process.
Traditional Medicare and Medicaid plans currently do
not cover Topical Hyperbaric Oxygen Therapy in the
home. However, therapy can be administered on an
out-patient basis at the doctors office or at a Wound
Care Center. Additionally patients receive treatment
when they are in-patients in a hospital or a nursing
home.
If private insurance reimbursement in unavailable or
traditional Medicare is the only insurance, reasonable
monthly rental rates can be arranged to accommodate
someone's needs.
-------------------
[Image]
[Image] - SELECTED FINANCIAL HIGHLIGHTS - [Image]
Market Cap. 2.63 million
Shares Outstanding: 14,007,000
52-Week High 1.0500 (04-24-02)
52-Week Low 0.1800 (10-10-02)
Recent Price: 0.28
Avg. Daily Volume: 31,700
HISTORICAL BUSINESS INFORMATION: The Company was
incorporated on March 28, 2000 under the laws of the
State of Colorado. Shareholders were asked to approve a
name change to Mariner Health Care, Inc. to more
accurately reflect the proposed business of the Company
to assist in the development of new healthcare
technologies. On May 24, 2002 the Company announced
they have authorized a 5 for 1 forward stock split. The
Company changed its corporate domicile from Colorado
to Nevada. On June 21, 2002 the Company announced in a
press release that it had identified numerous
opportunities in the healthcare industry, therefore,
the company would cease its operations in the Mortgage
industry and use its assets and experience, while
bringing on new management, to engage in the
development and incubation of small public and private
companies in the healthcare industry. On July 17, 2002
the Company changed its name to Mariner Healthcare Inc.
On August 5, 2002, the Company changed its name to
Advanced Healthcare Technologies, Inc. and applied for
a new symbol and cusip number. In August, 2002, the
Company completed its due diligence period and elected
to move forward with the acquisition of Advanced
Hyperbaric Technologies Inc. On August 5, 2002 the
Company announced that the final documents pertaining
to its acquisition of Advanced Hyperbaric Technologies,
Inc. had been completed in the stock for stock
transaction. Advanced Hyperbaric Technologies continues
to operate as a subsidiary of AVHC.
To view the SEC filings for AVHC (Still being filed as
Mariner Health Care) Click Here
To get a current quote and a list of recent press
releases, Click Here
[Image] - CONTACT - [Image]
Advanced Healthcare Technologies
124 Colts Neck Road
Farmingdale, NJ 07727
Company Contact: Phillip Loori
Tel: 800-327-4325
Email: philliploori@aol.com
Brokers and Analysts: Guy Vinci, Tel: 866-730-9604
Visit the Advanced Healthcare Technologies, Inc. Web
site at: www.advancedhealthcaretechnologies.com
Visit the Advanced Hyperbaric Technologies Web site at:
www.advanced-hyperbaric.com
--------------------------------------------------------
Want to feature YOUR company to over 1 MILLION
investors?
Click here to learn more about our programs or email us
directly at info@stockupticks.com
--------------------------------------------------------
Stockupticks Safe Harbor Statement: Statements
contained in this document, including those pertaining
to estimates and related plans, potential mergers and
acquisitions, estimates, growth, establishing new
markets, expansion into new markets and related plans
other than statements of historical fact, are
forward-looking statements subject to a number of
uncertainties that could cause actual results to differ
materially from statements made. StockUpTicks.com is a
property of Market Pathways Financial Relations
Incorporated (MP). MP provides no assurance as to the
subject company's plans or ability to effect any
planned and/or proposed actions. MP has no first-hand
knowledge of management and therefore cannot comment on
its capabilities, intent, resources, nor experience and
makes no attempt to do so. Statistical information,
dollar amounts, and market size data was provided by
the subject company and related sources believed by MP
to be reliable, but MP provides no assurance, and none
is given, as to the accuracy and completeness of this
information.
Disclaimer: StockUpTicks.com is a property of Market
Pathways Financial Relations Incorporated (MP). The
information, opinions and analysis contained herein are
based on sources believed to be reliable but no
representation, expressed or implied, is made as to its
accuracy, completeness or correctness. Past
performance is no guarantee of future results. This
report is a paid advertisement and is for information
purposes only and should not be used as the basis for
any investment decision. MP has been compensated with
192,000 shares of common stock of Advanced Healthcare
Technologies, Inc., by ARB Consulting, Inc., for
preparation and distribution of this report and other
advertising services. This constitutes a conflict of
interest as to MP’s ability to remain objective in its
communication regarding the subject company. Write or
call MP for detailed disclosure as required by Rule 17b
of the Securities Act of 1933/1934. MP is not an
investment advisor and this report is not investment
advice. This information is neither a solicitation to
buy nor an offer to sell securities but is a paid
advertisement. Information contained herein contains
forward-looking statements and is subject to
significant risks and uncertainties, which will affect
the results. The opinions contained herein reflect our
current judgment and are subject to change without
notice. MP and/or its affiliates, associates and
employees from time to time may have either a long or
short position in securities mentioned. Information
contained herein may not be reproduced in whole or in
part without the express written consent of Market
Pathways Financial Relations Incorporated.
[Image] [Image] [Image]
[Image]
© Stockupticks 2002,[Image] All rights reserved
[Image]
To unsubscribe from this newsletter click here and then hit SEND. If you
are using a text based email reader or the previous method does not
work, please follow the instructions located below.
---
You are currently subscribed to stockupticks as: @munged.ext
To unsubscribe send a blank email to leave-stockupticks-8666217V@lyris.stockupticks.com
--------------9CE9B79B89CAB3854BA3AEA7
Content-Type: text/html; charset=iso-8859-1
Content-Transfer-Encoding: 8bit
<!doctype html public "-//w3c//dtd html 4.0 transitional//en">
<html>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" BGCOLOR="#006699" >
<tr>
<td>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><a href="http://www.stockupticks.com"><img SRC="http://www.stockupticks.com/news_images/logo.gif" ALT="Stockupticks.com" HSPACE=5 VSPACE=5 NOSAVE BORDER=0 height=80 width=300></a></td>
<td ALIGN=RIGHT><img SRC="http://www.stockupticks.com/news_images/email_newsletter.gif" NOSAVE height=80 width=209></td>
</tr>
</table>
</td>
</tr>
<tr>
<td BGCOLOR="#003366">
<table BORDER=0 CELLSPACING=2 CELLPADDING=0 WIDTH="100%" >
<tr>
<td><b><font face="Arial, Helvetica, sans-serif"><font color="#FFFFFF"><font size=-1>Welcome
to the Stockupticks.com Newsletter!</font></font></font></b></td>
<td ALIGN=RIGHT><b><font face="Arial, Helvetica, sans-serif"><font color="#FFFFFF"><font size=-1>Issue
# 95 - November 22, 2002 </font></font></font></b></td>
</tr>
</table>
</td>
</tr>
<tr>
<td BGCOLOR="#FFFFFF"><img SRC="http://www.stockupticks.com/news_images/WSpacer.gif" NOSAVE BORDER=0 height=1 width=1></td>
</tr>
<tr>
<td>
<table BORDER=0 CELLSPACING=0 CELLPADDING=10 WIDTH="100%" >
<tr>
<td>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td><img SRC="http://www.stockupticks.com/news_images/UgaoNW.gif" NOSAVE BORDER=0 height=10 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#FFFFFF"><img SRC="http://www.stockupticks.com/news_images/Blocker.gif" NOSAVE BORDER=0 height=10 width=10></td>
<td ALIGN=RIGHT><img SRC="http://www.stockupticks.com/news_images/UgaoNE.gif" NOSAVE BORDER=0 height=10 width=10></td>
</tr>
<tr>
<td WIDTH="10" BGCOLOR="#FFFFFF"> </td>
<td WIDTH="100%" BGCOLOR="#FFFFFF">
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font color="#000000"><font size=-1>ADVANCED
HEALTHCARE TECHNOLOGIES, INC., (OTCBB: AVHC)</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<p>Dear Reader,
<p>We’ve been publishing <b>StockUpTicks</b> for several years and I’ve
written a lot of our editorials and profiles. There’s something interesting
in most every story we do and I enjoy drawing your attention to these often-undiscovered
stories.
<p>But not like today.
<p>Today I write you from the first person; from my own personal story
and experience.
<p>A short while ago I was with my cousin who is among my dearest friends.
I grew up just three doors down from him and his brothers, the eldest of
which is Ken, who had been hospitalized battling severe diabetes and a
wound that wouldn’t heal. I was with Ken’s brother when he took a call
from their father, my uncle, who was at the hospital
<p>Through the mobile phone I could hear my uncle in tears, telling my
cousin that they wanted to take Ken’s leg; that amputation looked to be
the only cure for a diabetic wound that wouldn’t heal. “Don’t let them
take his foot, son,” my elderly uncle told my cousin, imploring him to
plead with the doctors to try something else.
<p>When I spoke to Phillip Loori, <b>President of Advanced Healthcare Technologies,
Inc. (OTCBB: AVHC)</b> the first time, he told me about his company’s use
of <b>Hyperbaric Oxygen Therapy</b> to treat diabetic wounds that wouldn’t
heal. I told him about Ken’s plight and he kindly offered to do whatever
he could to help.
<p>I hung up the phone, called my cousin and said that this CEO had told
me about a therapy that could save Ken’s limb. I told him about Hyperbaric
Oxygen Therapy and what it was designed to do, how it might be perfect
for Ken.
<p>He interrupted me and said, “He’s fine now. That’s what saved his foot.
They didn’t have to amputate.”
<p>It’s one thing to hear about FDA approvals and clinical trials.
It’s another to know that the technology that our featured company today
is based upon is the reason your loved one still can walk.
<p>I hope you enjoy today’s profile.
<br>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font size=-1><font color="#000000"> </font><font color="#FFFFFF">-
</font><font color="#000000">ABOUT
AVHC </font><font color="#FFFFFF">-</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<center><table BORDER=0 WIDTH="100%" >
<tr>
<td><img SRC="http://www.stockupticks.com/news_images/o2.jpg" NOSAVE height=189 width=180></td>
<td><b>Advanced Healthcare Technologies</b> is a company that engages in
the acquisition of leading technologies in the healthcare industry. Principle
acquisition targets consist of companies in the Medical Devise and Medical
Service Industry.
<p>Recent Acquisitions include: Advanced Hyperbaric Technologies of Farmingdale,
NJ. Advanced Hyperbaric engages in the sale of Topical Hyperbaric Oxygen
chambers, which are marketed to various healthcare organizations including,
wound care clinics and physical therapy providers. AHT's principle products
include a portable topical Hyperbaric Oxygen chamber and a The Disposable
Sacral Topical Hyperbaric Oxygen System for smaller wounds. </td>
</tr>
</table></center>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font size=-1><font color="#000000"> </font><font color="#FFFFFF">-
</font><font color="#000000">THIS
WEEK'S NEWS FROM AVHC </font><font color="#FFFFFF">-</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<p><font face="Courier New,Courier"><font size=-1>Press Release</font></font>
<br><font face="Courier New,Courier"><font size=-1>Source: Advanced Hyperbaric
Technologies, Inc.</font></font>
<br><font face="Courier New,Courier"><font size=-1>Wednesday November 20,
7:48 pm ET </font></font>
<center>
<p><b>Advanced Hyperbaric Technologies, Inc., a Subsidiary of Advanced
Healthcare Technologies, Inc., Announces the Publishing of a New Topical
Hyperbaric Oxygen Study</b></center>
<p><b>FARMINGDALE, N.J., Nov. 20 /PRNewswire/ -- Advanced Hyperbaric Technologies,
Inc., a subsidiary of Advanced Healthcare Technologies, Inc. (OTC Bulletin
Board: AVHC - News)</b> today announces the publishing of a new topical
hyperbaric oxygen study.
<p>New Topical Hyperbaric Oxygen Study Published-
<p>A study, published this week in a leading medical journal, reports that
treatments using AHT 's Topical Hyperbaric Oxygen Products facilitate wound
healing and the full closure of pressure ulcers (bed sores) in patients
at long term care facilities (nursing homes). The study was conducted by
leading wound care researchers and specialists. The study, conducted over
a four-week period, demonstrated a 34.4% decrease in the average size of
Stage III and Stage IV ulcers by utilizing THBO Therapy. This is highly
significant, as many of these wound ulcers can remain open for years. The
study went on to show that by healing wounds with THBO Therapy, suffering
was reduced and quality of life was improved.
<p><i>To read the entire release and disclaimer, </i><a href="http://biz.yahoo.com/prnews/021120/law117_1.html">Click
Here</a>
<p>
<hr SIZE=4 WIDTH="34%">
<center>
<p><img SRC="http://www.stockupticks.com/news_images/o2.jpg" NOSAVE height=100 width=95></center>
<b>Advanced Hyperbaric Technologies</b><font size=+2>,</font> Inc. is a
wholley-owned subsidiary of AHT that's engaged in the sale of Topical Hyperbaric
Oxygen Chambers for the healing of open wounds. AHT's products are utilized
to treat patients who suffer from chronic open wounds due to diabetes,
vascular insufficiencies, post surgical infections, amputations, frostbite
and burns. The chambers are marketed to hospitals, doctors, wound care
clinics, nursing homes, and patients.
<center>
<p><img SRC="http://www.advanced-hyperbaric.com/h-chamber.jpg" NOSAVE BORDER=0 height=200 width=211>
<p><font color="#3333FF"><font size=+1>Topical Hyperbaric Oxygen raises
tissue oxygen levels at the wound site. </font></font></center>
<p><font color="#3333FF">Oxygen:</font> The body's fundamental mechanism
for healing itself. It is essential for any healing process - especially
chronic, recalcitrant open wounds. Oxygen is vital in collagen synthesis,
enhancement of fibroblasts, angiogenesis and leucocyte function.
<p><font color="#3333FF">Topical Hyperbaric Oxygen:</font> Raises tissue
oxygen levels at the wound site.
<p><font color="#3333FF">The Topical Hyperbaric Oxygen Extremity Chamber:</font>
Pulses topical hyperbaric oxygen at intermittent pressure directly to the
wound site. The result is oxygen levels are raised, wounds heal faster
and the cost to heal the wound is drastically reduced.
<br>
<center><table BORDER=0 WIDTH="80%" >
<tr>
<td><img SRC="http://www.advanced-hyperbaric.com/cs2/cs2-daemen.jpg" HSPACE=3 NOSAVE BORDER=1 height=136 width=125></td>
<td><font color="#FF9900"><font size=+1>Currently, AVHC is conducting research
at two facilities that specialize in wound healing and wound healing research. </font></font></td>
</tr>
</table></center>
<p>
<hr SIZE=4 WIDTH="34%">
<br>
<center><table BORDER WIDTH="95%" >
<tr>
<td><img SRC="http://www.advancedhealthcaretechnologies.com/Images/template1_quarters4_08.gif" NOSAVE BORDER=0 height=300 width=216></td>
<td><b><font color="#FF9900">One of the main goals of studies of this type
is to generate clinical information</font></b> necessary for <u>Medicare
</u>and
other <u>insurance providers</u> to pay for Topical Hyperbaric Oxygen Therapy
in patient's homes as well as on an outpatient basis.
<p><b><font color="#FF9900">The second research project is slated to begin
in December.</font></b> AHT plans to commit resources to the Northeast
Center for Special Care, a 250-bed spinal cord injury center. In the study,
researchers will investigate the clinical efficacy of both the disposable
sacral chamber and the extremity chamber.
<p><b><font color="#FF9900">The third research project is slated to begin
in January </font></b><font color="#000000">and </font>will begin at a
large Wound Care Center in New York. The research project will be a 100-patient
controlled study. A controlled study of this size is significant as clinicians,
when evaluating treatments, look for controlled studies with large numbers
of patients treated. </td>
</tr>
</table></center>
<br>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font size=-1><font color="#FFFFFF">-</font><font color="#000000">
THE MARKETS FOR AVHC INNOVATION </font><font color="#FFFFFF">-</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<p>AVHC has already signed a distribution agreement with Innovative Medical
Systems,
Inc. of St. Louis, Missouri, a medical distributor, which is marketing
the chambers in the states of Illinois, Missouri and Kansas.
<p>As AVHC continues to increase its sales efforts in the United States
they are beginning to focus on an even greater marketing opportunity, the
international market. AVHC is currently selling its products in Canada,
Spain and Israel.
<p>AVHC is communicating with medical device distributors in Japan, Jordan
and Ireland who have contacted the company seeking the opportunity to market
the chambers in their respective countries. Additionally, AHT is working
toward a strategic partner relationship with an overseas company to be
the master distributor of its THBO products in Europe.
<p>The European market is of great interest to AVHC as diabetic foot ulcers
continue to be the most common cause of lower extremity amputations in
Europe.
<br>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font size=-1><font color="#FFFFFF">-</font><font color="#000000">
COMPARATIVE TREATMENTS </font><font color="#FFFFFF">-</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<center>
<p><img SRC="http://www.advanced-hyperbaric.com/thos/thos.jpg" HSPACE=3 NOSAVE BORDER=0 height=129 width=200></center>
<p><font color="#3333FF">What is the advantage of utilizing THBO instead
of Full Body HBO?</font> The advantage of Topical delivery of Hyperbaric
Oxygen is the ability to achieve increased oxygen tension in the wound
without the risk of oxygen toxicity. There is no systemic absorption when
using the topical HBO chamber. When using the Full Body Chamber, you are
breathing the oxygen, and by doing so, you are directly exposing yourself
or the patient to the risk of central nervous system or pulmonary toxicity,
both of which have been reported in patients who have been treated in Full
Body Chambers.
<p><font color="#3333FF">Are there any side effects? </font>
<font color="#3333FF">Full Body</font>
<font color="#3333FF">Topical HBO</font>
<br>Congestive Heart Failure
Yes
No
<br>Severe Claustrophobia
Yes
No
<br>Congestive Heart Failure
Yes
No
<p>Nervous System Disorders
Yes
No
<br>Accelerates Cataract Growth
Yes
No
<p>Distorts Vision up to 8 week
Yes
No
<br>Pressure in the Ears and Sinus Cavity
Yes
No
<center>
<p><font color="#3333FF"><font size=+1>How much will it cost? </font></font>
<p>Full Body Chamber: $300.00 to $500.00 / day
<p>Topical HBO Chamber: $75.00 / day </center>
<p>
<hr SIZE=4 WIDTH="34%">
<center><font face="Verdana"><font color="#FF9900"><font size=+2>Insurance </font></font></font></center>
<p>Most private insurance companies, including some Medicare and Medicaid
HMO Plans are approving Topical Hyperbaric Oxygen Therapy on a case by
case basis for home car use. A prescription and a Letter of Medical Necessity
are required in order to start the pre-approval process.
<p>Traditional Medicare and Medicaid plans currently do not cover Topical
Hyperbaric Oxygen Therapy in the home. However, therapy can be administered
on an out-patient basis at the doctors office or at a Wound Care Center.
Additionally patients receive treatment when they are in-patients in a
hospital or a nursing home.
<p>If private insurance reimbursement in unavailable or traditional Medicare
is the only insurance, reasonable monthly rental rates can be arranged
to accommodate someone's needs.
<p>
<hr SIZE=4 WIDTH="34%">
<center>
<p><img SRC="http://www.advancedhealthcaretechnologies.com/Images/home_image.gif" NOSAVE BORDER=0 height=300 width=536></center>
<p><br>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font size=-1><font color="#FFFFFF">-</font><font color="#000000">
SELECTED FINANCIAL HIGHLIGHTS </font><font color="#FFFFFF">-</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<p>Market Cap. 2.63 million
<br>Shares Outstanding: 14,007,000
<p>52-Week High 1.0500 (04-24-02)
<br>52-Week Low 0.1800 (10-10-02)
<br>Recent Price: 0.28
<br>Avg. Daily Volume: 31,700
<p><font size=-2><b>HISTORICAL BUSINESS INFORMATION:</b> The Company was
incorporated on March 28, 2000 under the laws of the State of Colorado.
Shareholders were asked to approve a name change to Mariner Health Care,
Inc. to more accurately reflect the proposed business of the Company
to assist in the development of new healthcare technologies. On May
24, 2002 the Company announced they have authorized a 5 for 1 forward stock
split. The Company changed its corporate domicile from Colorado to
Nevada. On June 21, 2002 the Company announced in a press release that
it had identified numerous opportunities in the healthcare industry, therefore,
the company would cease its operations in the Mortgage industry and use
its assets and experience, while bringing on new management, to engage
in the development and incubation of small public and private companies
in the healthcare industry. On July 17, 2002 the Company changed
its name to Mariner Healthcare Inc. On August 5, 2002, the Company changed
its name to Advanced Healthcare Technologies, Inc. and applied for
a new symbol and cusip number. In August, 2002, the Company completed its
due diligence period and elected to move forward with the acquisition
of Advanced Hyperbaric Technologies Inc. On August 5, 2002 the Company
announced that the final documents pertaining to its acquisition of Advanced
Hyperbaric Technologies, Inc. had been completed in the stock for
stock transaction. Advanced Hyperbaric Technologies continues to operate
as a subsidiary of AVHC.</font>
<p>To view the SEC filings for AVHC (Still being filed as Mariner Health
Care) <a href="http://www.sec.gov/cgi-bin/srch-edgar?text=mariner+health+care&first=1993&last=2002&mode=Simple">Click
Here</a>
<p>To get a current quote and a list of recent press releases, <a href="http://finance.yahoo.com/q?s=AVHC.OB">Click
Here</a>
<br>
<table BORDER=0 CELLSPACING=0 CELLPADDING=0 WIDTH="100%" >
<tr>
<td WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part1.gif" NOSAVE BORDER=0 height=20 width=10></td>
<td ALIGN=CENTER WIDTH="100%" BGCOLOR="#BDC5FF"><b><font face="Verdana"><font color="#FFFFFF"> <font size=-1>-</font></font><font size=-1><font color="#000000">
CONTACT </font><font color="#FFFFFF">-</font></font></font></b></td>
<td ALIGN=RIGHT WIDTH="1"><img SRC="http://www.stockupticks.com/news_images/part2.gif" NOSAVE BORDER=0 height=20 width=50></td>
</tr>
</table>
<p><b><font color="#999999">Advanced Healthcare Technologies</font></b>
<br> 124 Colts Neck
Road
<br> Farmingdale, NJ 07727
<p>Company Contact: Phillip Loori
<br>Tel: 800-327-4325
<br>Email: <a href="mailto:philliploori@aol.com">philliploori@aol.com</a>
<p>Brokers and Analysts: Guy Vinci, Tel: 866-730-9604
<p>Visit the Advanced Healthcare Technologies, Inc. Web site at: <font color="#3333FF"><a href="http://www.advancedhealthcaretechnologies.com">www.advancedhealthcaretechnologies.com </a></font>
<p>Visit the Advanced Hyperbaric Technologies Web site at: <a href="http://www.advanced-hyperbaric.com">www.advanced-hyperbaric.com </a>
<center>
<p>
<hr WIDTH="100%" SIZE="1"><b><font face="Arial, Helvetica, sans-serif"><font color="#990000"><font size=+1>Want
to feature YOUR company to over 1 MILLION investors?</font></font></font></b>
<br><b><i><font face="Arial, Helvetica, sans-serif"><font size=-1><a href="http://www.stockupticks.com/hidden">Click
here</a></font> </font></i><font face="Arial, Helvetica, sans-serif"><font size=-1>to
learn more about our programs or email us directly at <a href="mailto:info@stockupticks.com">info@stockupticks.com</a></font></font></b></center>
<hr WIDTH="100%" SIZE="1">
<br><font face="Verdana, Arial, Helvetica, sans-serif"><font size=-2><b><font color="#000000">Stockupticks
Safe Harbor Statement:</font></b> Statements contained in this document,
including those pertaining to estimates and related plans, potential mergers
and acquisitions, estimates, growth, establishing new markets, expansion
into new markets and related plans other than statements of historical
fact, are forward-looking statements subject to a number of uncertainties
that could cause actual results to differ materially from statements made.
StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated
(MP). MP provides no assurance as to the subject company's plans
or ability to effect any planned and/or proposed actions. MP has no first-hand
knowledge of management and therefore cannot comment on its capabilities,
intent, resources, nor experience and makes no attempt to do so.
Statistical information, dollar amounts, and market size data was provided
by the subject company and related sources believed by MP to be reliable,
but MP provides no assurance, and none is given, as to the accuracy and
completeness of this information. </font></font>
<p><font face="Verdana, Arial, Helvetica, sans-serif"><font size=-2><b>Disclaimer:</b>
StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated
(MP). The information, opinions and analysis contained herein are
based on sources believed to be reliable but no representation, expressed
or implied, is made as to its accuracy, completeness or correctness.
Past performance is no guarantee of future results. This report is a paid
advertisement and is for information purposes only and should not be used
as the basis for any investment decision. <font color="#000000">MP has
been compensated with 192,000 shares of common stock of Advanced Healthcare
Technologies, Inc., by ARB Consulting, Inc., for preparation and distribution
of this report and other advertising services. This constitutes a conflict
of interest as to MP’s ability to remain obje</font>ctive in its communication
regarding the subject company. Write or call MP for detailed disclosure
as required by Rule 17b of the Securities Act of 1933/1934. MP is
not an investment advisor and this report is not investment advice. This
information is neither a solicitation to buy nor an offer to sell securities
but is a paid advertisement. Information contained herein contains
forward-looking statements and is subject to significant risks and uncertainties,
which will affect the results. The opinions contained herein reflect
our current judgment and are subject to change without notice. MP and/or
its affiliates, associates and employees from time to time may have either
a long or short position in securities mentioned. Information contained
herein may not be reproduced in whole or in part without the express written
consent of Market Pathways Financial Relations Incorporated.</font></font>
<br> </td>
<td WIDTH="10" BGCOLOR="#FFFFFF"> </td>
</tr>
<tr>
<td><img SRC="http://www.stockupticks.com/news_images/UgaoSW.gif" NOSAVE BORDER=0 height=10 width=10></td>
<td ALIGN=CENTER BGCOLOR="#FFFFFF"><img SRC="http://www.stockupticks.com/news_images/Blocker.gif" NOSAVE BORDER=0 height=10 width=10></td>
<td ALIGN=RIGHT><img SRC="http://www.stockupticks.com/news_images/UgaoSE.gif" NOSAVE BORDER=0 height=10 width=10></td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr>
<td BGCOLOR="#FFFFFF"><img SRC="http://www.stockupticks.com/news_images/WSpacer.gif" NOSAVE BORDER=0 height=1 width=1></td>
</tr>
<tr>
<td ALIGN=CENTER HEIGHT="20" BGCOLOR="#003366"><b><font face="Verdana"><font color="#FFFFFF"><font size=-2>©
Stockupticks 2002,<img SRC="http://www.stockupticks.com/cgi-bin/Count.cgi?sh=F&df=stockupticks.dat" NOSAVE height=1 width=1>
All rights reserved</font></font></font></b></td>
</tr>
<tr>
<td BGCOLOR="#FFFFFF"><img SRC="http://www.stockupticks.com/news_images/WSpacer.gif" NOSAVE BORDER=0 height=1 width=1></td>
</tr>
</table>
<p><font face="Verdana, Arial, Helvetica, sans-serif"><font size=-1>To
unsubscribe from this newsletter <a href="mailto:leave-stockupticks-8666217V@lyris.stockupticks.com">click
here</a> and then hit <b>SEND</b>. If you are using a text based email
reader or the previous method does not work, please follow the instructions
located below.</font></font>
<br>
<br>
<br>
---
You are currently subscribed to stockupticks as: @munged.ext
To unsubscribe send a blank email to leave-stockupticks-8666217V@lyris.stockupticks.com
</html>
--------------9CE9B79B89CAB3854BA3AEA7--
-----------------------------------------------------------
Registrant:
Levelogic, Inc. (LEVELOGIC-DOM)
701 B Street, Suite #480
San Diego, CA 92101
US
Domain Name: LEVELOGIC.COM
Administrative Contact:
Kang, Arthur (AK1499) arthur@levelogic.com
Levelogic, Inc.
701 B Street, Suite #480
San Diego, CA 92101
US
619-231-2923 123 123 1234
Technical Contact:
Administrator, DNS (OFBRQWNODI) dns-admin@levelogic.com
701 B Street, Suite #480
San Diego, CA 92101
US
(619) 231-2923 123 123 1234
Record expires on 25-Sep-2011.
Record created on 26-Sep-1998.
Database last updated on 22-Nov-2002 18:59:33 EST.
Domain servers in listed order:
NS1.LEVELOGIC.COM 64.157.40.141
NS2.LEVELOGIC.COM 64.157.40.142
levelogic.com has address 64.157.40.141
www.levelogic.com is an alias for orion.levelogic.com.
orion.levelogic.com has address 64.157.40.141
delta.levelogic.com has address 64.157.40.131
Search results for: 64.157.40.131
OrgName: Level 3 Communications, Inc.
OrgID: LVLT
NetRange: 64.152.0.0 - 64.159.255.255
CIDR: 64.152.0.0/13
NetName: LC-ORG-ARIN
NetHandle: NET-64-152-0-0-1
Parent: NET-64-0-0-0-0
NetType: Direct Allocation
NameServer: NS1.LEVEL3.NET
NameServer: NS2.LEVEL3.NET
Comment: ADDRESSES WITHIN THIS BLOCK ARE NON-PORTABLE
RegDate: 2000-06-08
Updated: 2001-05-30
TechHandle: LC-ORG-ARIN
TechName: level Communications
TechPhone: +1-877-453-8353
TechEmail: ipaddressing@level3.com
OrgName: Level 3 Communications, Inc.
OrgID: LVLT
Address: 1450 Infinite Drive Louisville CO 80027
Country: US
Comment:
RegDate: 1998-05-22
Updated: 2001-05-30
# ARIN Whois database, last updated 2002-11-21 19:05
Organization:
CRG
Clarence Melby
1220 Martingale
Kahalla, HI 99436
US
Phone: (888) 275-1949
Fax..: (973) 475-1820
Email: admin@stockupticks.com
Registrar Name....: Register.com
Registrar Whois...: whois.register.com
Registrar Homepage: http://www.register.com
Domain Name: STOCKUPTICKS.COM
Created on..............: Tue, Jan 30, 2001
Expires on..............: Thu, Jan 30, 2003
Record last updated on..: Tue, Sep 17, 2002
Administrative Contact:
CRG
Clarence Melby
1220 Martingale
Kahalla, HI 99461
US
Phone: (888) 754-1874
Fax..: (973) 475-1241
Email: info@stockupticks.com
Technical Contact:
CRG
Clarence Melby
1220 Martingale
Kahalla, HI 99436
US
Phone: (888) 275-1949
Fax..: (973) 475-1820
Email: admin@stockupticks.com
Zone Contact:
CRG
Clarence Melby
1220 Martingale
Kahalla, HI 99436
US
Phone: (888) 275-1949
Fax..: (973) 475-1820
Email: admin@stockupticks.com
Domain servers in listed order:
NS1.LEVELOGIC.COM 64.157.40.132
NS2.LEVELOGIC.COM 209.75.61.3
stockupticks.com has address 64.157.40.139
www.stockupticks.com is an alias for stockupticks.com.
lyris.stockupticks.com is an alias for delta.levelogic.com.
delta.levelogic.com has address 64.157.40.131
TOASTEDspam.com toasted spam dot com